Grants and Contributions:

Back to search

Title:

Artificial Intelligence for Design and Development of Novel Bioactive Flavonoids

Agreement Number:

997415

Agreement Value:

$75,000.00

Agreement Date:

Nov 1, 2022 - Oct 31, 2023

Description:

To build an effective computer-aided drug design pipeline to screen large libraries of bioactive compounds into smaller clusters of predicted active molecules that will present improved biological properties (bioavailability, efficacy and affinity for target proteins). It will focus on generating molecules that will be filtered on their calculated physiochemical properties to select the most drug-like analogs with structural similarity to existing cannflavins and exhibiting optimal ligand-target interactions. The predictive power of this platform accelerates the selection of promising lead compounds, provide insight into drug-receptor interactions and is beneficial in terms of cost savings, time-to-market and product portfolio expansion.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Mississauga, Ontario, CA L4W 5K4

Reference Number:

172-2022-2023-Q3-997415

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

717319081

Recipient Type:

For-profit organization

Recipient's Operating Name:

Canurta Inc.

Recipient's Legal Name:

Canurta Inc.

Federal Riding Name:

Mississauga--Malton

Federal Riding Number:

35062

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

32519